Tag: #Global Trends

GC Biopharma has successfully developed and validated a proprietary assay designed to precisely measure impurities linked to thromboembolic risks. This... Read more

Halozyme Therapeutics Inc. has finalized a global exclusive collaboration and licensing agreement with Vertex Pharmaceuticals Incorporated. Under this pact, Vertex... Read more

AC Immune SA and Eli Lilly and Company have officially amended their 2018 licensing and collaboration agreement to advance the... Read more

Pharmaceutical giant Biocon has officially commenced the commercial launch of two biosimilars, Aukelso and Bosaya, in the United States. These... Read more

Amgen has announced that a subcutaneous version of its blockbuster drug Tepezza—a treatment for thyroid eye disease (TED)—successfully met both... Read more

Sanofi has announced Phase 2 trial results for Lunsekimig, a bispecific biologic targeting two well-known drivers of inflammation: TSLP and... Read more

In a strategic move to enhance patient convenience and treatment adherence, Vertex Pharmaceuticals has entered into a licensing agreement to... Read more

Following a sharp decline in demand for the HPV vaccine (Gardasil) in China, Merck & Co. and its domestic distribution... Read more

On April 1, 2026, the U.S. Food and Drug Administration (FDA) approved Foundayo (orforglipron), a once-daily obesity pill developed by... Read more